Bizzoca Cinzia, Fiore Felicia, Aquilino Fabrizio, Fedele Salvatore, Salvo Maria Di, Lucarelli Giuseppe, Vincenti Leonardo
Department of General Surgery "Ospedaliera". Polyclinic Hospital of Bari, Piazza G. Cesare, 11, 70124 Bari, Italy.
Department of General Surgery. National Institute of Gastroenterology Saverio de Bellis, Research Hospital, via Turi 27, 70013 Castellana Grotte, Bari, Italy. via Turi 27, 70013 Castellana Grotte, Bari, Italy.
Surg Pract Sci. 2023 Apr 20;13:100171. doi: 10.1016/j.sipas.2023.100171. eCollection 2023 Jun.
Simple hepatic cysts are commonly detected in the general population, both solitary and associated with Adult Dominant Polycystic Kidney Disease (ADPKD). Laparoscopic fenestration is a surgical option adopted as first-line treatment and to treat complications. The techniques reported in the literature are associated with cyst recurrence in up to 41% of cases.
From 2012 to May 2021, 19 symptomatic patients diagnosed with simple HCs underwent an innovative technique for laparoscopic fenestration, which includes simultaneous ethanol injection into the residual cavity. The median follow up was 57 (range 4-116) months. We retrospectively analysed symptomatic relief obtained in the short and long term as primary outcome. We also evaluated the postoperative outcome, recurrence and re-intervention rates.
11 patients (of 19) were female (58 %), with a median age of 58 (range 31-78) years. Most patients (17 of 19) experienced relief of symptoms after intervention (89,5 %). Radiological recurrence occurred in 21% of patients; nevertheless, only one patient, affected by ADPKD, experienced clinical relapse with abdominal discomfort. No patient needed reintervention. There was no major morbidity (Clavien-Dindo III-IV) nor 90-day mortality. The technique allowed early removal of abdominal drainage (median 2.5 days).
Laparoscopic fenestration of a simple hepatic cyst, with simultaneous ethanol injection, combines the advantages of the laparoscopic approach with those of injecting sclerosing agent. The described technique is associated with symptomatic relief and a favourable outcome in the postoperative period, as well as with good long term results.
单纯性肝囊肿在普通人群中很常见,有单发的,也有与成人显性多囊肾病(ADPKD)相关的。腹腔镜开窗术是作为一线治疗及治疗并发症而采用的一种手术选择。文献报道的技术在高达41%的病例中与囊肿复发相关。
2012年至2021年5月,19例诊断为单纯性肝囊肿的有症状患者接受了一种创新的腹腔镜开窗技术,该技术包括同时向残余腔隙注射乙醇。中位随访时间为57(范围4 - 116)个月。我们回顾性分析了作为主要结局的短期和长期症状缓解情况。我们还评估了术后结局、复发率和再次干预率。
19例患者中有11例(58%)为女性,中位年龄为58(范围31 - 78)岁。大多数患者(19例中的17例)在干预后症状缓解(89.5%)。21%的患者出现影像学复发;然而,只有1例患有ADPKD的患者出现腹部不适的临床复发。没有患者需要再次干预。没有严重并发症(Clavien - Dindo III - IV级),也没有90天死亡率。该技术允许早期拔除腹腔引流管(中位时间2.5天)。
单纯性肝囊肿的腹腔镜开窗术同时注射乙醇,将腹腔镜手术方法的优点与注射硬化剂的优点结合起来。所描述的技术与症状缓解、术后良好结局以及良好的长期结果相关。